Dianthus Therapeutics Ownership 2024 | Who Owns Dianthus Therapeutics Now?
Institutional Ownership
47.55%
Insider Ownership
2.23%
Retail Ownership
50.23%
Institutional Holders
43.00
Dianthus Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FIDUCIARY TRUST CO | - | - | - | -30,555 | -100.00% | - | Sep 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -779 | -100.00% | - | Sep 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -71,463 | -100.00% | - | Sep 30, 2023 |
| CREDIT SUISSE AG/ | - | - | - | -149,300 | -100.00% | - | Sep 30, 2023 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -27,369 | -100.00% | - | Sep 30, 2023 |
| MORGAN STANLEY | - | - | - | -16,866 | -100.00% | - | Sep 30, 2023 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -457,690 | -100.00% | - | Sep 30, 2023 |
| UMB BANK, N.A. | - | - | - | -742 | -100.00% | - | Sep 30, 2023 |
| ROYAL BANK OF CANADA | - | - | - | -5,843 | -100.00% | - | Sep 30, 2023 |
| HARBOR CAPITAL ADVISORS, INC. | - | - | - | -167,454 | -100.00% | - | Sep 30, 2023 |
| BESSEMER GROUP INC | - | - | - | -237,292 | -100.00% | - | Sep 30, 2023 |
| HARVARD MANAGEMENT CO INC | - | - | - | -332,610 | -100.00% | - | Sep 30, 2023 |
| BNP PARIBAS ARBITRAGE, SNC | - | - | - | -4,474 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -120,269 | -100.00% | - | Sep 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -357,690 | -100.00% | - | Sep 30, 2023 |
| CORSAIR CAPITAL MANAGEMENT, L.P. | - | - | - | -100,000 | -100.00% | - | Sep 30, 2023 |
| RATHBONES GROUP PLC | - | - | - | -10,000 | -100.00% | - | Sep 30, 2023 |
| BLACKROCK INC. | - | - | - | -364,168 | -100.00% | - | Sep 30, 2023 |
| CHEYNE CAPITAL MANAGEMENT (UK) LLP | - | - | - | -47,170 | -100.00% | - | Sep 30, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -60,404 | -100.00% | - | Sep 30, 2023 |
Dianthus Therapeutics's largest institutional shareholder is FIDUCIARY TRUST CO, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FIDUCIARY TRUST CO | - | - | - | -30,555 | -100.00% | - | Sep 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -779 | -100.00% | - | Sep 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -71,463 | -100.00% | - | Sep 30, 2023 |
| CREDIT SUISSE AG/ | - | - | - | -149,300 | -100.00% | - | Sep 30, 2023 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -27,369 | -100.00% | - | Sep 30, 2023 |
| MORGAN STANLEY | - | - | - | -16,866 | -100.00% | - | Sep 30, 2023 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -457,690 | -100.00% | - | Sep 30, 2023 |
| UMB BANK, N.A. | - | - | - | -742 | -100.00% | - | Sep 30, 2023 |
| ROYAL BANK OF CANADA | - | - | - | -5,843 | -100.00% | - | Sep 30, 2023 |
| HARBOR CAPITAL ADVISORS, INC. | - | - | - | -167,454 | -100.00% | - | Sep 30, 2023 |
| BESSEMER GROUP INC | - | - | - | -237,292 | -100.00% | - | Sep 30, 2023 |
| HARVARD MANAGEMENT CO INC | - | - | - | -332,610 | -100.00% | - | Sep 30, 2023 |
| BNP PARIBAS ARBITRAGE, SNC | - | - | - | -4,474 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -120,269 | -100.00% | - | Sep 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -357,690 | -100.00% | - | Sep 30, 2023 |
| CORSAIR CAPITAL MANAGEMENT, L.P. | - | - | - | -100,000 | -100.00% | - | Sep 30, 2023 |
| RATHBONES GROUP PLC | - | - | - | -10,000 | -100.00% | - | Sep 30, 2023 |
| BLACKROCK INC. | - | - | - | -364,168 | -100.00% | - | Sep 30, 2023 |
| CHEYNE CAPITAL MANAGEMENT (UK) LLP | - | - | - | -47,170 | -100.00% | - | Sep 30, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -60,404 | -100.00% | - | Sep 30, 2023 |
The largest Dianthus Therapeutics shareholder by % of total assets is FIDUCIARY TRUST CO. The company owns 0.00 shares of Dianthus Therapeutics (MGTA), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | - | - | - | -50 | -100.00% | - | Sep 30, 2023 |
| ALLWORTH FINANCIAL LP | - | - | - | -375 | -100.00% | - | Sep 30, 2023 |
| UMB BANK, N.A. | - | - | - | -742 | -100.00% | - | Sep 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -779 | -100.00% | - | Sep 30, 2023 |
| BNP PARIBAS ARBITRAGE, SNC | - | - | - | -4,474 | -100.00% | - | Sep 30, 2023 |
| ROYAL BANK OF CANADA | - | - | - | -5,843 | -100.00% | - | Sep 30, 2023 |
| RATHBONES GROUP PLC | - | - | - | -10,000 | -100.00% | - | Sep 30, 2023 |
| SOUND VIEW WEALTH ADVISORS GROUP, LLC | - | - | - | -10,500 | -100.00% | - | Sep 30, 2023 |
| UBS GROUP AG | - | - | - | -11,177 | -100.00% | - | Sep 30, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -12,190 | -100.00% | - | Sep 30, 2023 |
| MORGAN STANLEY | - | - | - | -16,866 | -100.00% | - | Sep 30, 2023 |
| XTX TOPCO LTD | - | - | - | -26,932 | -100.00% | - | Sep 30, 2023 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -27,369 | -100.00% | - | Sep 30, 2023 |
| FIDUCIARY TRUST CO | - | - | - | -30,555 | -100.00% | - | Sep 30, 2023 |
| CHEYNE CAPITAL MANAGEMENT (UK) LLP | - | - | - | -47,170 | -100.00% | - | Sep 30, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -60,404 | -100.00% | - | Sep 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -71,463 | -100.00% | - | Sep 30, 2023 |
| CORSAIR CAPITAL MANAGEMENT, L.P. | - | - | - | -100,000 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -120,269 | -100.00% | - | Sep 30, 2023 |
| CREDIT SUISSE AG/ | - | - | - | -149,300 | -100.00% | - | Sep 30, 2023 |
As of Sep 30 2023, Dianthus Therapeutics's largest institutional buyer is INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC. The company purchased -50.00 stocks of MGTA, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | - | - | - | -3,791,698 | -100.00% | - | Sep 30, 2023 |
| ALPHABET INC. | - | - | - | -3,339,138 | -100.00% | - | Sep 30, 2023 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -457,690 | -100.00% | - | Sep 30, 2023 |
| BLACKROCK INC. | - | - | - | -364,168 | -100.00% | - | Sep 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -357,690 | -100.00% | - | Sep 30, 2023 |
| HARVARD MANAGEMENT CO INC | - | - | - | -332,610 | -100.00% | - | Sep 30, 2023 |
| BESSEMER GROUP INC | - | - | - | -237,292 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA ADVISERS, LP | - | - | - | -177,400 | -100.00% | - | Sep 30, 2023 |
| HARBOR CAPITAL ADVISORS, INC. | - | - | - | -167,454 | -100.00% | - | Sep 30, 2023 |
| CREDIT SUISSE AG/ | - | - | - | -149,300 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -120,269 | -100.00% | - | Sep 30, 2023 |
| CORSAIR CAPITAL MANAGEMENT, L.P. | - | - | - | -100,000 | -100.00% | - | Sep 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -71,463 | -100.00% | - | Sep 30, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -60,404 | -100.00% | - | Sep 30, 2023 |
| CHEYNE CAPITAL MANAGEMENT (UK) LLP | - | - | - | -47,170 | -100.00% | - | Sep 30, 2023 |
| FIDUCIARY TRUST CO | - | - | - | -30,555 | -100.00% | - | Sep 30, 2023 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -27,369 | -100.00% | - | Sep 30, 2023 |
| XTX TOPCO LTD | - | - | - | -26,932 | -100.00% | - | Sep 30, 2023 |
| MORGAN STANLEY | - | - | - | -16,866 | -100.00% | - | Sep 30, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -12,190 | -100.00% | - | Sep 30, 2023 |
As of Sep 30 2023, Dianthus Therapeutics's biggest institutional seller is ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC. The company sold -3.79M shares of MGTA, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | - | - | - | -3,791,698 | -100.00% | - | Sep 30, 2023 |
| ALPHABET INC. | - | - | - | -3,339,138 | -100.00% | - | Sep 30, 2023 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -457,690 | -100.00% | - | Sep 30, 2023 |
| BLACKROCK INC. | - | - | - | -364,168 | -100.00% | - | Sep 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -357,690 | -100.00% | - | Sep 30, 2023 |
| HARVARD MANAGEMENT CO INC | - | - | - | -332,610 | -100.00% | - | Sep 30, 2023 |
| BESSEMER GROUP INC | - | - | - | -237,292 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA ADVISERS, LP | - | - | - | -177,400 | -100.00% | - | Sep 30, 2023 |
| HARBOR CAPITAL ADVISORS, INC. | - | - | - | -167,454 | -100.00% | - | Sep 30, 2023 |
| CREDIT SUISSE AG/ | - | - | - | -149,300 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -120,269 | -100.00% | - | Sep 30, 2023 |
| CORSAIR CAPITAL MANAGEMENT, L.P. | - | - | - | -100,000 | -100.00% | - | Sep 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -71,463 | -100.00% | - | Sep 30, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -60,404 | -100.00% | - | Sep 30, 2023 |
| CHEYNE CAPITAL MANAGEMENT (UK) LLP | - | - | - | -47,170 | -100.00% | - | Sep 30, 2023 |
| FIDUCIARY TRUST CO | - | - | - | -30,555 | -100.00% | - | Sep 30, 2023 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -27,369 | -100.00% | - | Sep 30, 2023 |
| XTX TOPCO LTD | - | - | - | -26,932 | -100.00% | - | Sep 30, 2023 |
| MORGAN STANLEY | - | - | - | -16,866 | -100.00% | - | Sep 30, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -12,190 | -100.00% | - | Sep 30, 2023 |
| UBS GROUP AG | - | - | - | -11,177 | -100.00% | - | Sep 30, 2023 |
| SOUND VIEW WEALTH ADVISORS GROUP, LLC | - | - | - | -10,500 | -100.00% | - | Sep 30, 2023 |
| RATHBONES GROUP PLC | - | - | - | -10,000 | -100.00% | - | Sep 30, 2023 |
| ROYAL BANK OF CANADA | - | - | - | -5,843 | -100.00% | - | Sep 30, 2023 |
| BNP PARIBAS ARBITRAGE, SNC | - | - | - | -4,474 | -100.00% | - | Sep 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -779 | -100.00% | - | Sep 30, 2023 |
| UMB BANK, N.A. | - | - | - | -742 | -100.00% | - | Sep 30, 2023 |
| ALLWORTH FINANCIAL LP | - | - | - | -375 | -100.00% | - | Sep 30, 2023 |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | - | - | - | -50 | -100.00% | - | Sep 30, 2023 |
Dianthus Therapeutics's largest sold out institutional shareholder by shares sold is ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC, sold -3.79M shares, valued at -, as of undefined.
Dianthus Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| CORNERCAP GROUP OF FUNDS /VA/ | 0.95% | 68,263 | 33,914 | 98.73% | Sep 30, 2022 |
| TEKLA LIFE SCIENCES INVESTORS | 0.24% | 114,141 | - | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.16% | 400,248 | - | - | Jan 31, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.09% | 78,290 | - | - | Mar 31, 2024 |
| ALGER FUNDS | 0.08% | 79,507 | - | - | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.08% | 672,300 | - | - | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.06% | 150,000 | - | - | Mar 28, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.05% | 24,259 | - | - | Mar 31, 2024 |
| Advantage Advisers Xanthus Fund, L.L.C. | 0.04% | 113,402 | - | - | Mar 31, 2024 |
| ACAP Strategic Fund | 0.02% | 251,066 | - | - | Mar 31, 2024 |
| UBS FUNDS | 0.02% | 75,005 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.01% | 18,703 | - | - | Jan 31, 2024 |
| Harbor ETF Trust | 0.01% | 57,473 | - | - | Jan 31, 2024 |
| Harbor ETF Trust | 0.01% | 46,905 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 54,237 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 4,575 | - | - | Mar 31, 2024 |
| HARBOR FUNDS | 0.01% | 143,270 | - | - | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 18,523 | - | - | Feb 29, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.01% | 55,275 | - | - | Mar 31, 2024 |
| HARBOR FUNDS | 0.01% | 121,064 | - | - | Jan 31, 2024 |
| ALPS ETF Trust | 0.00% | 56,924 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,897,129 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 683 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 109,100 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 332,522 | - | - | Feb 29, 2024 |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 0.00% | 60,000 | - | - | Mar 31, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 14,029 | - | - | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 33,990 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 27,369 | - | - | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,719 | - | - | Mar 31, 2024 |
| GPS Funds I | 0.00% | 2,196 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 11,888 | - | - | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 87,864 | - | - | Feb 29, 2024 |
| SunAmerica Specialty Series | 0.00% | 171 | - | - | Apr 30, 2021 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,500 | - | - | Mar 31, 2024 |
| North Square Investments Trust | 0.00% | 2,440 | - | - | Jan 31, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 1,000,000 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 8,579 | - | - | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 395 | - | - | Mar 31, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 2,028 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,288 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 5,900 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 10,083 | - | - | Mar 28, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 285 | - | - | Dec 31, 2023 |
| PRINCIPAL FUNDS, INC. | 0.00% | 423,521 | - | - | Feb 29, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 3,900 | - | - | Mar 31, 2023 |
| PGIM ETF TRUST | 0.00% | 4,139 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,396 | - | - | Feb 29, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 220,782 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 640 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 7,090 | - | - | Jan 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 103,505 | - | - | Feb 29, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 16,100 | - | - | Jan 31, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 162,988 | - | - | Mar 28, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 5,534 | - | - | Mar 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 2,522 | - | - | Dec 31, 2023 |
| RYDEX DYNAMIC FUNDS | 0.00% | 159 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 11,089 | - | - | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 2,187 | - | - | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 3,990 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 178 | - | - | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 29 | - | - | Dec 31, 2023 |
| TIAA-CREF FUNDS | 0.00% | 69,591 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 4,908 | - | - | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 600 | - | - | Mar 28, 2024 |
| PROSHARES TRUST | 0.00% | 4,953 | - | - | Feb 29, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 1,699 | - | - | Mar 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 6,132 | - | - | Feb 29, 2024 |
| HC CAPITAL TRUST | 0.00% | 486 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,217 | - | - | Feb 29, 2024 |
| Brighthouse Funds Trust II | 0.00% | 10,252 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 25,747 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 192 | - | - | Jan 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 3,299 | - | - | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 9,114 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 6,850 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 1,508 | - | - | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 56 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 1,093 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 370 | - | - | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 3,047 | - | - | Jan 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 10,990 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 2,446 | - | - | Dec 31, 2023 |
| iSHARES TRUST | 0.00% | 19,872 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 2,418 | - | - | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 4,565 | - | - | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 3,568 | - | - | Mar 31, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 53 | - | - | Jan 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 2,524 | - | - | Mar 28, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 7,300 | - | - | Feb 29, 2024 |
| John Hancock Funds II | 0.00% | 3,863 | - | - | Feb 29, 2024 |
Dianthus Therapeutics's largest mutual fund holder by % of total assets is "CORNERCAP GROUP OF FUNDS /VA/", owning 68.26K shares, compromising 0.95% of its total assets.
Dianthus Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 23 | 43 | -15.69% |
| 31 Mar, 23 | 51 | -1.92% |
| 31 Dec, 22 | 52 | -22.39% |
| 30 Sep, 22 | 67 | -5.63% |
| 30 Jun, 22 | 71 | -15.48% |
| 31 Mar, 22 | 84 | -7.69% |
| 31 Dec, 21 | 91 | -1.09% |
| 30 Sep, 21 | 92 | -2.13% |
| 30 Jun, 21 | 94 | 4.44% |
| 31 Mar, 21 | 90 | - |
| 31 Dec, 20 | 90 | -3.23% |
| 30 Sep, 20 | 93 | -2.11% |
| 30 Jun, 20 | 95 | 33.80% |
| 31 Mar, 20 | 71 | -5.33% |
| 31 Dec, 19 | 75 | 4.17% |
| 30 Sep, 19 | 72 | 4.35% |
| 30 Jun, 19 | 69 | 9.52% |
| 31 Mar, 19 | 63 | 21.15% |
| 31 Dec, 18 | 52 | 6.12% |
| 30 Sep, 18 | 49 | 2.08% |
| 30 Jun, 18 | 48 | - |
As of 30 Jun 23, 43 institutions are holding Dianthus Therapeutics's shares, representing a decrease of -15.69% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 23 | 28,834,243 | -2.22% |
| 31 Mar, 23 | 29,489,573 | 5.49% |
| 31 Dec, 22 | 27,955,148 | -39.79% |
| 30 Sep, 22 | 46,426,800 | 2.18% |
| 30 Jun, 22 | 45,438,307 | -5.04% |
| 31 Mar, 22 | 47,847,703 | 0.20% |
| 31 Dec, 21 | 47,751,764 | 25.98% |
| 30 Sep, 21 | 37,903,641 | 1.32% |
| 30 Jun, 21 | 37,409,138 | 6.01% |
| 31 Mar, 21 | 35,288,202 | 8.60% |
| 31 Dec, 20 | 32,493,864 | 1.84% |
| 30 Sep, 20 | 31,906,973 | -1.99% |
| 30 Jun, 20 | 32,554,508 | 17.33% |
| 31 Mar, 20 | 27,746,019 | -3.82% |
| 31 Dec, 19 | 28,848,091 | 2.78% |
| 30 Sep, 19 | 28,067,675 | -1.36% |
| 30 Jun, 19 | 28,454,935 | 14.98% |
| 31 Mar, 19 | 24,748,120 | 12.41% |
| 31 Dec, 18 | 22,015,398 | 62.44% |
| 30 Sep, 18 | 13,552,929 | 0.14% |
| 30 Jun, 18 | 13,534,169 | - |
Dianthus Therapeutics (MGTA) has 28.83M shares outstanding as of 30 Jun 23, down -2.22% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 23 | 47.55% | 2.01% |
| 31 Mar, 23 | 48.63% | 2.19% |
| 31 Dec, 22 | 47.08% | 0.77% |
| 30 Sep, 22 | 78.33% | 1.31% |
| 30 Jun, 22 | 77.26% | 1.17% |
| 31 Mar, 22 | 81.37% | 1.23% |
| 31 Dec, 21 | 81.23% | 1.94% |
| 30 Sep, 21 | 64.70% | 1.33% |
| 30 Jun, 21 | 69.66% | 1.32% |
| 31 Mar, 21 | 72.66% | 1.61% |
| 31 Dec, 20 | 67.20% | 1.54% |
| 30 Sep, 20 | 66.12% | 0.98% |
| 30 Jun, 20 | 82.18% | 1.65% |
| 31 Mar, 20 | 70.48% | 1.16% |
| 31 Dec, 19 | 77.94% | 1.49% |
| 30 Sep, 19 | 72.29% | 1.20% |
| 30 Jun, 19 | 77.61% | 1.42% |
| 31 Mar, 19 | 74.05% | 0.52% |
| 31 Dec, 18 | 119.72% | 2.20% |
| 30 Sep, 18 | 73.70% | 1.36% |
| 30 Jun, 18 | 73.60% | - |
As of 30 Jun 23, Dianthus Therapeutics is held by 47.55% institutional shareholders, representing a 2.01% growth compared to 31 Mar 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 23 | 13 | -45.83% |
| 31 Mar, 23 | 24 | 4.35% |
| 31 Dec, 22 | 23 | 4.55% |
| 30 Sep, 22 | 22 | -35.29% |
| 30 Jun, 22 | 34 | 6.25% |
| 31 Mar, 22 | 32 | -25.58% |
| 31 Dec, 21 | 43 | -6.52% |
| 30 Sep, 21 | 46 | -14.81% |
| 30 Jun, 21 | 54 | 38.46% |
| 31 Mar, 21 | 39 | -9.30% |
| 31 Dec, 20 | 43 | -10.42% |
| 30 Sep, 20 | 48 | -17.24% |
| 30 Jun, 20 | 58 | 70.59% |
| 31 Mar, 20 | 34 | -8.11% |
| 31 Dec, 19 | 37 | 12.12% |
| 30 Sep, 19 | 33 | -19.51% |
| 30 Jun, 19 | 41 | - |
| 31 Mar, 19 | 41 | 46.43% |
| 31 Dec, 18 | 28 | -9.68% |
| 30 Sep, 18 | 31 | -35.42% |
| 30 Jun, 18 | 48 | - |
13 institutional shareholders have increased their position in MGTA stock as of 30 Jun 23 compared to 24 in the previous quarter (a -45.83% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 23 | 11 | 10.00% |
| 31 Mar, 23 | 10 | -28.57% |
| 31 Dec, 22 | 14 | -41.67% |
| 30 Sep, 22 | 24 | 33.33% |
| 30 Jun, 22 | 18 | -35.71% |
| 31 Mar, 22 | 28 | 33.33% |
| 31 Dec, 21 | 21 | -12.50% |
| 30 Sep, 21 | 24 | 14.29% |
| 30 Jun, 21 | 21 | -25.00% |
| 31 Mar, 21 | 28 | 27.27% |
| 31 Dec, 20 | 22 | 29.41% |
| 30 Sep, 20 | 17 | -26.09% |
| 30 Jun, 20 | 23 | 27.78% |
| 31 Mar, 20 | 18 | - |
| 31 Dec, 19 | 18 | - |
| 30 Sep, 19 | 18 | 80.00% |
| 30 Jun, 19 | 10 | 42.86% |
| 31 Mar, 19 | 7 | -56.25% |
| 31 Dec, 18 | 16 | 220.00% |
| 30 Sep, 18 | 5 | - |
| 30 Jun, 18 | - | - |
11 institutional shareholders have reduced their position in MGTA stock as of 30 Jun 23 compared to 10 in the previous quarter (a 10.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 23 | 43 | -15.69% | 28,834,243 | -2.22% | 47.55% | 2.01% | 13 | -45.83% | 11 | 10.00% |
| 31 Mar, 23 | 51 | -1.92% | 29,489,573 | 5.49% | 48.63% | 2.19% | 24 | 4.35% | 10 | -28.57% |
| 31 Dec, 22 | 52 | -22.39% | 27,955,148 | -39.79% | 47.08% | 0.77% | 23 | 4.55% | 14 | -41.67% |
| 30 Sep, 22 | 67 | -5.63% | 46,426,800 | 2.18% | 78.33% | 1.31% | 22 | -35.29% | 24 | 33.33% |
| 30 Jun, 22 | 71 | -15.48% | 45,438,307 | -5.04% | 77.26% | 1.17% | 34 | 6.25% | 18 | -35.71% |
| 31 Mar, 22 | 84 | -7.69% | 47,847,703 | 0.20% | 81.37% | 1.23% | 32 | -25.58% | 28 | 33.33% |
| 31 Dec, 21 | 91 | -1.09% | 47,751,764 | 25.98% | 81.23% | 1.94% | 43 | -6.52% | 21 | -12.50% |
| 30 Sep, 21 | 92 | -2.13% | 37,903,641 | 1.32% | 64.70% | 1.33% | 46 | -14.81% | 24 | 14.29% |
| 30 Jun, 21 | 94 | 4.44% | 37,409,138 | 6.01% | 69.66% | 1.32% | 54 | 38.46% | 21 | -25.00% |
| 31 Mar, 21 | 90 | - | 35,288,202 | 8.60% | 72.66% | 1.61% | 39 | -9.30% | 28 | 27.27% |
| 31 Dec, 20 | 90 | -3.23% | 32,493,864 | 1.84% | 67.20% | 1.54% | 43 | -10.42% | 22 | 29.41% |
| 30 Sep, 20 | 93 | -2.11% | 31,906,973 | -1.99% | 66.12% | 0.98% | 48 | -17.24% | 17 | -26.09% |
| 30 Jun, 20 | 95 | 33.80% | 32,554,508 | 17.33% | 82.18% | 1.65% | 58 | 70.59% | 23 | 27.78% |
| 31 Mar, 20 | 71 | -5.33% | 27,746,019 | -3.82% | 70.48% | 1.16% | 34 | -8.11% | 18 | - |
| 31 Dec, 19 | 75 | 4.17% | 28,848,091 | 2.78% | 77.94% | 1.49% | 37 | 12.12% | 18 | - |
| 30 Sep, 19 | 72 | 4.35% | 28,067,675 | -1.36% | 72.29% | 1.20% | 33 | -19.51% | 18 | 80.00% |
| 30 Jun, 19 | 69 | 9.52% | 28,454,935 | 14.98% | 77.61% | 1.42% | 41 | - | 10 | 42.86% |
| 31 Mar, 19 | 63 | 21.15% | 24,748,120 | 12.41% | 74.05% | 0.52% | 41 | 46.43% | 7 | -56.25% |
| 31 Dec, 18 | 52 | 6.12% | 22,015,398 | 62.44% | 119.72% | 2.20% | 28 | -9.68% | 16 | 220.00% |
| 30 Sep, 18 | 49 | 2.08% | 13,552,929 | 0.14% | 73.70% | 1.36% | 31 | -35.42% | 5 | - |
| 30 Jun, 18 | 48 | - | 13,534,169 | - | 73.60% | - | 48 | - | - | - |
Dianthus Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Dianthus Therapeutics's stock was made by Soteropoulos Paula on Sep 13 2023, selling 28,792 shares at $8.44 per share (valued at $243.00K). The last insider buy of MGTA was made by Fairmount Funds Management LLC on Oct 03 2023, buying 24,670 shares at $13.63 per share (worth $336.25K).
Dianthus Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2023 | 13 | 7 | 185.71% |
| Q1 2023 | - | 2 | - |
| Q4 2022 | 5 | - | - |
| Q3 2022 | 9 | - | - |
| Q2 2022 | 19 | - | - |
| Q1 2022 | 8 | - | - |
| Q4 2021 | 1 | - | - |
| Q3 2021 | 13 | 9 | 144.44% |
| Q2 2021 | 12 | 1 | 1200.00% |
| Q1 2021 | 5 | 1 | 500.00% |
| Q4 2020 | 2 | 7 | 28.57% |
| Q3 2020 | 1 | - | - |
| Q2 2020 | 11 | 1 | 1100.00% |
| Q1 2020 | 6 | 5 | 120.00% |
| Q4 2019 | 7 | 24 | 29.17% |
| Q3 2019 | - | 7 | - |
| Q2 2019 | 9 | 4 | 225.00% |
| Q1 2019 | 8 | 4 | 200.00% |
| Q3 2018 | 1 | - | - |
| Q2 2018 | 20 | 73 | 27.40% |
13 total buy trades, and 7 total sell trades (buy/sell ratio of 1.86%) were made by Dianthus Therapeutics's insiders, as of Q3 2023.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2023 | 6 | - | - |
| Q1 2023 | - | 2 | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | 7 | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | - | - |
| Q3 2020 | - | - | - |
| Q2 2020 | 1 | - | - |
| Q1 2020 | - | 3 | - |
| Q4 2019 | - | 17 | - |
| Q3 2019 | - | 7 | - |
| Q2 2019 | - | 4 | - |
| Q1 2019 | - | 2 | - |
| Q3 2018 | - | - | - |
| Q2 2018 | 2 | - | - |
As of Q3 2023, Insider owners conducted 6 open market buy trades and 0 open market sell trades of Dianthus Therapeutics's stocks.
MGTA Ownership FAQ
Who Owns Dianthus Therapeutics?
Dianthus Therapeutics is owned by institutional shareholders (47.55%), insiders (2.23%), and public (50.23%). The largest institutional shareholder of Dianthus Therapeutics is FIDUCIARY TRUST CO (0% of total shares) and the top mutual fund owner is CORNERCAP GROUP OF FUNDS /VA/ (0.95% of total shares).
Who are the major institutional shareholders of Dianthus Therapeutics?
Dianthus Therapeutics's major institutional shareholders are FIDUCIARY TRUST CO, WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, CREDIT SUISSE AG/, and CHARLES SCHWAB INVESTMENT MANAGEMENT INC. The top five shareholders own together 0% of the company's share outstanding.
How many Dianthus Therapeutics shareholders are there?
As of Jun 2023, there are 43 institutional shareholders of Dianthus Therapeutics.
What percentage of Dianthus Therapeutics is owned by FIDUCIARY TRUST CO?
FIDUCIARY TRUST CO owns 0 shares of Dianthus Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Sep 2023).
What percentage of Dianthus Therapeutics is owned by WELLS FARGO & COMPANY/MN?
As of Sep 2023, WELLS FARGO & COMPANY/MN holds 0 shares of Dianthus Therapeutics (MGTA), compromising 0% of the company, valued at $0.
What percentage of Dianthus Therapeutics is owned by NORTHERN TRUST CORP?
NORTHERN TRUST CORP is the third largest holder of Dianthus Therapeutics. The company owns 0 of the company's shares outstanding (worth $0).